SomaLogic Inc. [NASDAQ: SLGC] traded at a low on 05/11/22, posting a -13.03 loss after which it closed the day’ session at $4.27. The company report on April 21, 2022 that SomaLogic to Announce First Quarter 2022 Financial Results.
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the first quarter 2022 after market close on Thursday, May 12, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 535-4027 for domestic callers or (270) 215-9487 for international callers, using conference ID: 3567018. A live audio webcast and an archive of the presentation will be available through the Investors page of SomaLogic’s corporate website at https://investors.somalogic.com/.
The results of the trading session contributed to over 4042606 shares changing hands. Over the past one week, the price volatility of SomaLogic Inc. stands at 13.26% while the volatility over the past one month is 8.16%.
The market cap for SLGC stock reached $814.37 million, with 182.72 million shares outstanding and 148.04 million shares in the current float. Compared to the average trading volume of 1.13M shares, SLGC reached a trading volume of 4042606 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about SomaLogic Inc. [SLGC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLGC shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLGC stock is a recommendation set at 1.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for SomaLogic Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 01, 2022. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on December 14, 2021, representing the official price target for SomaLogic Inc. stock. Previously, the target price had yet another raise to $16, while Jefferies analysts kept a Buy rating on SLGC stock.
The Average True Range (ATR) for SomaLogic Inc. is set at 0.53, with the Price to Sales ratio for SLGC stock in the period of the last 12 months amounting to 9.98. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 3.45.
How has SLGC stock performed recently?
SomaLogic Inc. [SLGC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -38.29. With this latest performance, SLGC shares dropped by -37.48% in over the last four-week period, additionally sinking by -68.04% over the last 6 months – not to mention a drop of -64.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLGC stock in for the last two-week period is set at 22.60, with the RSI for the last a single of trading hit 17.29, and the three-weeks RSI is set at 26.80 for SomaLogic Inc. [SLGC]. The present Moving Average for the last 50 days of trading for this stock 7.28, while it was recorded at 5.42 for the last single week of trading, and 10.07 for the last 200 days.
SomaLogic Inc. [SLGC]: Deeper insight into the fundamentals
SomaLogic Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 23.20 and a Current Ratio set at 23.60.
Insider trade positions for SomaLogic Inc. [SLGC]
There are presently around $535 million, or 58.40% of SLGC stock, in the hands of institutional investors. The top three institutional holders of SLGC stocks are: CASDIN CAPITAL, LLC with ownership of 12,389,082, which is approximately 0% of the company’s market cap and around 0.20% of the total institutional ownership; ARK INVESTMENT MANAGEMENT LLC, holding 10,390,335 shares of the stock with an approximate value of $51.02 million in SLGC stocks shares; and MADRYN ASSET MANAGEMENT, LP, currently with $38.69 million in SLGC stock with ownership of nearly 0% of the company’s market capitalization.
Positions in SomaLogic Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 67 institutional holders increased their position in SomaLogic Inc. [NASDAQ:SLGC] by around 33,872,207 shares. Additionally, 31 investors decreased positions by around 14,381,924 shares, while 22 investors held positions by with 60,703,449 shares. The mentioned changes placed institutional holdings at 108,957,580 shares, according to the latest SEC report filing. SLGC stock had 32 new institutional investments in for a total of 13,137,162 shares, while 19 institutional investors sold positions of 7,358,044 shares during the same period.